Literature DB >> 28607002

ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration.

Himjyot Jaiswal1, Jan Benada2,3, Erik Müllers1, Karen Akopyan1, Kamila Burdova2, Tobias Koolmeister4, Thomas Helleday4, René H Medema5, Libor Macurek6, Arne Lindqvist7.   

Abstract

After DNA damage, the cell cycle is arrested to avoid propagation of mutations. Arrest in G2 phase is initiated by ATM-/ATR-dependent signaling that inhibits mitosis-promoting kinases such as Plk1. At the same time, Plk1 can counteract ATR-dependent signaling and is required for eventual resumption of the cell cycle. However, what determines when Plk1 activity can resume remains unclear. Here, we use FRET-based reporters to show that a global spread of ATM activity on chromatin and phosphorylation of ATM targets including KAP1 control Plk1 re-activation. These phosphorylations are rapidly counteracted by the chromatin-bound phosphatase Wip1, allowing cell cycle restart despite persistent ATM activity present at DNA lesions. Combining experimental data and mathematical modeling, we propose a model for how the minimal duration of cell cycle arrest is controlled. Our model shows how cell cycle restart can occur before completion of DNA repair and suggests a mechanism for checkpoint adaptation in human cells.
© 2017 The Authors.

Entities:  

Keywords:  zzm321990ATMzzm321990; zzm321990ATRzzm321990; G2; Plk1; checkpoint recovery

Mesh:

Substances:

Year:  2017        PMID: 28607002      PMCID: PMC5510006          DOI: 10.15252/embj.201696082

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  63 in total

1.  The molecular basis of FHA domain:phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms.

Authors:  D Durocher; I A Taylor; D Sarbassova; L F Haire; S L Westcott; S P Jackson; S J Smerdon; M B Yaffe
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

2.  Inhibition of Aurora A in response to DNA damage.

Authors:  A Krystyniak; C Garcia-Echeverria; C Prigent; S Ferrari
Journal:  Oncogene       Date:  2006-01-19       Impact factor: 9.867

3.  Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress.

Authors:  Niels Mailand; Simon Bekker-Jensen; Jiri Bartek; Jiri Lukas
Journal:  Mol Cell       Date:  2006-08-04       Impact factor: 17.970

4.  Rapid destruction of human Cdc25A in response to DNA damage.

Authors:  N Mailand; J Falck; C Lukas; R G Syljuâsen; M Welcker; J Bartek; J Lukas
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

5.  The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours.

Authors:  Jenita Rauta; Emma-Leena Alarmo; Päivikki Kauraniemi; Ritva Karhu; Tuula Kuukasjärvi; Anne Kallioniemi
Journal:  Breast Cancer Res Treat       Date:  2005-10-28       Impact factor: 4.872

6.  Positive regulation of Wee1 by Chk1 and 14-3-3 proteins.

Authors:  J Lee; A Kumagai; W G Dunphy
Journal:  Mol Biol Cell       Date:  2001-03       Impact factor: 4.138

7.  Polo-like kinase-1 is a target of the DNA damage checkpoint.

Authors:  V A Smits; R Klompmaker; L Arnaud; G Rijksen; E A Nigg; R H Medema
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

8.  Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity.

Authors:  Dmitry V Bulavin; Oleg N Demidov; Shin'ichi Saito; Paivikki Kauraniemi; Crissy Phillips; Sally A Amundson; Concetta Ambrosino; Guido Sauter; Angel R Nebreda; Carl W Anderson; Anne Kallioniemi; Albert J Fornace; Ettore Appella
Journal:  Nat Genet       Date:  2002-05-20       Impact factor: 38.330

9.  Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway.

Authors:  Yael Ziv; Dana Bielopolski; Yaron Galanty; Claudia Lukas; Yoichi Taya; David C Schultz; Jiri Lukas; Simon Bekker-Jensen; Jiri Bartek; Yosef Shiloh
Journal:  Nat Cell Biol       Date:  2006-07-23       Impact factor: 28.824

10.  Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells.

Authors:  Marcel A T M van Vugt; Alexandra Brás; René H Medema
Journal:  Mol Cell       Date:  2004-09-10       Impact factor: 17.970

View more
  13 in total

1.  How the cell cycle enforces senescence.

Authors:  Helena Silva Cascales; Erik Müllers; Arne Lindqvist
Journal:  Aging (Albany NY)       Date:  2017-10-30       Impact factor: 5.682

2.  Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer/T cell lymphoma.

Authors:  Xianxian Sui; Canjing Zhang; Yudong Jiang; Jianan Zhou; Chen Xu; Feng Tang; Bobin Chen; Huiwen Xu; Songmei Wang; Xuanyi Wang
Journal:  Ann Transl Med       Date:  2020-06

3.  A methylation-phosphorylation switch determines Plk1 kinase activity and function in DNA damage repair.

Authors:  Weizhe Li; Hong-Yan Wang; Xiaolu Zhao; Hongguo Duan; Binghua Cheng; Yafei Liu; Mengjie Zhao; Wenjie Shu; Yuchao Mei; Zengqi Wen; Mingliang Tang; Lin Guo; Guohong Li; Qiang Chen; Xiaoqi Liu; Hai-Ning Du
Journal:  Sci Adv       Date:  2019-03-06       Impact factor: 14.136

4.  WIP1 Promotes Homologous Recombination and Modulates Sensitivity to PARP Inhibitors.

Authors:  Kamila Burdova; Radka Storchova; Matous Palek; Libor Macurek
Journal:  Cells       Date:  2019-10-15       Impact factor: 6.600

5.  A limited number of double-strand DNA breaks is sufficient to delay cell cycle progression.

Authors:  Jeroen van den Berg; Anna G Manjón; Karoline Kielbassa; Femke M Feringa; Raimundo Freire; René H Medema
Journal:  Nucleic Acids Res       Date:  2018-11-02       Impact factor: 16.971

6.  Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon.

Authors:  Monika Burocziova; Kamila Burdova; Andra S Martinikova; Petr Kasparek; Petra Kleiblova; Stine A Danielsen; Marianna Borecka; Gabriela Jenikova; Lucie Janečková; Jozef Pavel; Petra Zemankova; Michaela Schneiderova; Lucie Schwarzova; Ivana Ticha; Xiao-Feng Sun; Katerina Jiraskova; Vaclav Liska; Ludmila Vodickova; Pavel Vodicka; Radislav Sedlacek; Zdenek Kleibl; Ragnhild A Lothe; Vladimír Korinek; Libor Macurek
Journal:  Cell Death Dis       Date:  2019-10-28       Impact factor: 8.469

7.  A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants.

Authors:  Ivana Ticha; Jan Hojny; Romana Michalkova; Ondrej Kodet; Eva Krkavcova; Nikola Hajkova; Kristyna Nemejcova; Michaela Bartu; Radek Jaksa; Miroslav Dura; Madiha Kanwal; Andra S Martinikova; Libor Macurek; Petra Zemankova; Zdenek Kleibl; Pavel Dundr
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

Review 8.  DNA replication and mitotic entry: A brake model for cell cycle progression.

Authors:  Bennie Lemmens; Arne Lindqvist
Journal:  J Cell Biol       Date:  2019-11-11       Impact factor: 10.539

Review 9.  Working on Genomic Stability: From the S-Phase to Mitosis.

Authors:  Sara Ovejero; Avelino Bueno; María P Sacristán
Journal:  Genes (Basel)       Date:  2020-02-20       Impact factor: 4.096

10.  Truncated PPM1D Prevents Apoptosis in the Murine Thymus and Promotes Ionizing Radiation-Induced Lymphoma.

Authors:  Andra S Martinikova; Monika Burocziova; Miroslav Stoyanov; Libor Macurek
Journal:  Cells       Date:  2020-09-10       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.